New cancer clinical trial: Phase II Proof of Concept Single-arm Trial of Nivolumab in Platinum Recurrent or Refractory Metastatic Germ Cell Tumors

Published on: October 31, 2018 at 12:00PM
Condition:   Germ Cell Tumors
Intervention:   Drug: Nivolumab
Sponsors:   Hospital Beatriz Ângelo;   Universidade Nova de Lisboa;   Bristol-Myers Squibb;   Instituto de Patologia e Imunologia Molecular da Universidade do Porto
Recruiting
https://ift.tt/2Rr0nTq